The DOI matches its Crossref record; 96 of the 96 references it cites were found in a registry or an index.
Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution
Abstract
Dementia with Lewy bodies (DLB) is a neuropsychiatric disease associated with extrapyramidal features which differ from those of Parkinson's disease, including reduced effectiveness of L-dopa and severe sensitivity reactions to neuroleptic drugs. Distinguishing Alzheimer's disease from DLB is clinically relevant in terms of prognosis and appropriate treatment. Dopaminergic activities have been investigated at coronal levels along the rostrocaudal striatal axis from a post-mortem series of 25 DLB, 14 Parkinson's disease and 17 Alzheimer's disease patients and 20 elderly controls. [(3)H]Mazindol binding to the dopamine uptake site was significantly reduced in the caudal putamen in DLB compared with controls (57%), but not as extensively as in Parkinson's disease (75%), and was unchanged in Alzheimer's disease. Among three dopamine receptors measured (D1, D2 and D3), the most striking changes were apparent in relation to D2. In DLB, [(3)H]raclopride binding to D2 receptors was significantly reduced in the caudal putamen (17%) compared with controls, and was significantly lower than in Parkinson's disease at all levels. D2 binding was significantly elevated at all coronal levels in Parkinson's disease compared with controls, most extensively in the rostral putamen (71%). There was no change from the normal pattern of D2 binding in Alzheimer's disease. The only significant alteration in D1 binding ([(3)H]SCH23390) in the groups examined was an elevation (30%) in the caudal striatum in Parkinson's disease. There were no differences in D3 binding, measured using [(3)H]7-OH-DPAT, in DLB compared with controls. A slight, significant decrease in D3 binding in the caudal striatum of Parkinson's disease (13%) patients and an increase in Alzheimer's disease (20%) in the dorsal striatum at the level of the nucleus accumbens were found. The concentration and distribution of dopamine were disrupted in both DLB and Parkinson's disease, although in the caudate nucleus the loss of dopamine in DLB was uniform whereas in Parkinson's disease the loss was greater caudally. In the caudal putamen, dopamine was reduced by 72% in DLB and by 90% in Parkinson's disease. The homovanillic acid : dopamine ratio, a metabolic index, indicated compensatory increased turnover in Parkinson's disease, which was absent in DLB despite the loss of substantia nigra neurons (49%), dopamine and uptake sites. These differences between DLB, Parkinson's disease and Alzheimer's disease may explain some characteristics of the extrapyramidal features of DLB and its limited response to L-dopa and severe neuroleptic sensitivity. The distinct changes in the rostrocaudal pattern of expression of dopaminergic parameters are relevant to the interpretation of the in vivo imaging and diagnosis of DLB.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Mirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961
McKeith, I. G., Galasko, D., Kosaka, K., Perry, E. K., Dickson, D. W., Hansen, L. A., Salmon, D. P., Lowe, J., Mirra, S. S., Byrne, E. J., et al. (1996) · Neurology · doi:10.1212/wnl.47.5.1113 · Cited by 3,960 · cited 3×
“, 1990); if dementia developed within a year of onset of motor symptoms the cases were assigned to the DLB group (McKeith et al., 1996).”
BackgroundMethodSelf-citationBernheimer, H., Birkmayer, W., Hornykiewicz, O., Jellinger, K., & Seitelberger, F. (1973) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(73)90175-5 · Cited by 2,651
Consortium to Establish a Registry for Alzheimer's Disease (CERAD)
Fillenbaum, G. G., & Heyman, A. (2002) · Principles and Practice of Geriatric Psychiatry · doi:10.1002/0470846410.ch42(iii · Cited by 2,410
Uneven Pattern of Dopamine Loss in the Striatum of Patients with Idiopathic Parkinson's Disease
Kish, S. J., Shannak, K., & Hornykiewicz, O. (1988) · New England Journal of Medicine · doi:10.1056/nejm198804073181402 · Cited by 1,953
Lévesque, D., Diaz, J., Pilon, C., Martres, M. P., Giros, B., Souil, E., Schott, D., Morgat, J. L., Schwartz, J. C., & Sokoloff, P. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.17.8155 · Cited by 674
Neuroleptic sensitivity in patients with senile dementia of Lewy body type.
McKeith, I., Fairbairn, A., Perry, R., Thompson, P., & Perry, E. (1992) · BMJ · doi:10.1136/bmj.305.6855.673 · Cited by 624
Self-citationSenile dementia of Lewy body type
Perry, R. H., Irving, D., Blessed, G., Fairbairn, A., & Perry, E. K. (1990) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(90)90236-g · Cited by 571
Self-citationPerry, E. K., Curtis, M., Dick, D. J., Candy, J. M., Atack, J. R., Bloxham, C. A., Blessed, G., Fairbairn, A., Tomlinson, B. E., & Perry, R. H. (1985) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.48.5.413 · Cited by 571
Self-citationKinnear, P. R., & Gray, C. D. (1994) · Cited by 522
Booij, J., Tissingh, G., Boer, G. J., Speelman, J. D., Stoof, J. C., Janssen, A. G., Wolters, E. C., & van Royen, E. A. (1997) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.62.2.133 · Cited by 439
Distribution of D1- and D2-Dopamine Receptors, and Dopamine and Its Metabolites in the Human Brain
Hall, H., Sedvall, G., Magnusson, O., Kopp, J., Halldin, C., & Farde, L. (1994) · Neuropsychopharmacology · doi:10.1038/sj.npp.1380111 · Cited by 419
The D3 Dopamine Receptor: Neurobiology and Potential Clinical Relevance
Levant, B. (1997) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01327-9 · Cited by 385
Murray, A. M., Ryoo, H. L., Gurevich, E., & Joyce, J. N. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.23.11271 · Cited by 325
Molecular alterations in the neostriatum of human cocaine addicts
Hurd, Y. L., & Herkenham, M. (1993) · Synapse · doi:10.1002/syn.890130408 · Cited by 323
HORNYKIEWICZ, O. (1973) · British Medical Bulletin · doi:10.1093/oxfordjournals.bmb.a070990 · Cited by 317
SEEMAN, P. (1987) · Neuropsychopharmacology · doi:10.1016/0893-133x(87)90004-2 · Cited by 316
Abnormal dopamine uptake sites in postmortem striatum from patients with tourette's syndrome
Singer, H. S., Hahn, I., & Moran, T. H. (1991) · Annals of Neurology · doi:10.1002/ana.410300408 · Cited by 273
Aral, H., Kosaka, K., & Iizuka, R. (1984) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1984.tb00913.x · Cited by 255
Gurevich, E. V. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830150047009 · Cited by 248
Antonini, A. (1997) · Brain · doi:10.1093/brain/120.12.2187 · Cited by 241
Gnanalingham, K. K., Byrne, E. J., Thornton, A., Sambrook, M. A., & Bannister, P. (1997) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.62.3.243 · Cited by 233
Wilson, J. M., Levey, A. I., Rajput, A., Ang, L., Guttman, M., Shannak, K., Niznik, H. B., Hornykiewicz, O., Pifl, C., & Kish, S. J. (1996) · Neurology · doi:10.1212/wnl.47.3.718 · Cited by 222
Malmberg, A., Jackson, D. M., Eriksson, A., & Mohell, N. (1993) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13652-3 · Cited by 213
[3H]spiperone binding, dopamine and HVA concentrations in Parkinson's disease and supranuclear palsy
Bokobza, B., Ruberg, M., Scatton, B., Javoy-Agid, F., & Agid, Y. (1984) · European Journal of Pharmacology · doi:10.1016/0014-2999(84)90238-3 · Cited by 210
Neuroleptic sensitivity in dementia with Lewy bodies and Alzheimer's disease
Ballard, C., Grace, J., McKeith, L., & Holmes, C. (1998) · The Lancet · doi:10.1016/s0140-6736(05)78999-6 · Cited by 209
Self-citationMonoaminergic neurotransmitters, their precursors and metabolites in brains of Alzheimer patients
Storga, D., Vrecko, K., Birkmayer, J. G. D., & Reibnegger, G. (1996) · Neuroscience Letters · doi:10.1016/0304-3940(95)12256-7 · Cited by 208
Antonini, A., Schwarz, J., Oertel, W. H., Pogarell, O., & Leenders, K. L. (1997) · Movement Disorders · doi:10.1002/mds.870120107 · Cited by 208
Dopamine D3 receptor mRNA and binding sites in human brain
Landwehrmeyer, B., Mengod, G., & Palacios, J. M. (1993) · Molecular Brain Research · doi:10.1016/0169-328x(93)90188-u · Cited by 192
Age-dependent decline in human brain dopamine D1 and D2 receptors
Rinne, J. O., Lönnberg, P., & Marjamäki, P. (1990) · Brain Research · doi:10.1016/0006-8993(90)90423-9 · Cited by 191
Dopamine receptors in human brain: Autoradiographic distribution of D1 sites
Cortés, R., Gueye, B., Pazos, A., Probst, A., & Palacios, J. M. (1989) · Neuroscience · doi:10.1016/0306-4522(89)90178-4 · Cited by 190
Brücke, T., Asenbaum, S., Pirker, W., Djamshidian, S., Wenger, S., Wöber, C., Müller, C., & Podreka, I. (1997) · PubMed · Cited by 186
Lévesque, D., Martres, M. P., Diaz, J., Griffon, N., Lammers, C. H., Sokoloff, P., & Schwartz, J. C. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.5.1719 · Cited by 180
Antonini, A., Schwarz, J., Oertel, W. H., et al. (1994) · Neurology · doi:10.1212/wnl.44.7.1325 · Cited by 178
Guttman, M., Burkholder, J., Kish, S. J., Hussey, D., Wilson, A., DaSilva, J., & Houle, S. (1997) · Neurology · doi:10.1212/wnl.48.6.1578 · Cited by 174
Antonini, A., Vontobel, P., Psylla, M., Gunther, I., Maguire, P. R., Missimer, J., & Leenders, K. L. (1995) · Archives of Neurology · doi:10.1001/archneur.1995.00540360061017 · Cited by 174
Parallel loss of presynaptic and postsynaptic dopamine markers in normal aging
Volkow, N. D., Wang, G. J., Fowler, J. S., Ding, Y. S., Gur, R. C., Gatley, J., Logan, J., Moberg, P. J., Hitzemann, R., Smith, G., et al. (1998) · Annals of Neurology · doi:10.1002/ana.410440125 · Cited by 171
Donnemiller, E., Heilmann, J., Wenning, G. K., Berger, W., Decristoforo, C., Moncayo, R., Poewe, W., & Ransmayr, G. (1997) · European Journal of Nuclear Medicine · doi:10.1007/bf01728771 · Cited by 167
Measurement of the dopaminergic degeneration in Parkinson’s disease with [123I]β-CIT and SPECT
Brücke, T., Asenbaum, S., Pirker, W., Djamshidian, S., Wenger, S., Wöber, C., Müller, C., & Podreka, I. (1997) · Journal of Neural Transmission. Supplementa · doi:10.1007/978-3-7091-6842-4_2 · Cited by 160
Moratalla, R., Quinn, B., DeLanney, L. E., Irwin, I., Langston, J. W., & Graybiel, A. M. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.9.3859 · Cited by 158
Clinical and Neuropathological Findings in Lewy Body Dementias
Galasko, D., Katzman, R., Salmon, D. P., & Hansen, L. (1996) · Brain and Cognition · doi:10.1006/brcg.1996.0040 · Cited by 153
Age‐related changes in the human nigrostriatal dopaminergic system
Keyser, J. D., Ebinger, G., & Vauquelin, G. (1990) · Annals of Neurology · doi:10.1002/ana.410270210 · Cited by 149
Neurotransmitters in basal ganglia and cortex of Alzheimer's disease with and without Lewy bodies
Langlais, P. J., Thai, L., Hansen, L. A., Galasko, D., Alford, M. F., & Masliah, E. (1993) · Neurology · doi:10.1212/wnl.43.10.1927 · Cited by 144
Kish, S. J., Chang, L. J., Mirchandani, L., Shannak, K. S., & Hornykiewicz, O. (1985) · Annals of Neurology · doi:10.1002/ana.410180504 · Cited by 142
Tatsch, K., Schwarz, J., Mozley, P. D., Linke, R., Pogarell, O. M., Oertel, W. H., Fieber, R. S., Hahn, K. M., & Kung, H. F. (1997) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/bf00881814 · Cited by 140
Tissingh, G., Bergmans, P., Booij, J., Winogrodzka, A., van Royen, E. A., Stoof, J. C., & Wolters, E. C. (1997) · Journal of Neurology · doi:10.1007/s004150050168 · Cited by 140
Murray, A. M., Weihmueller, F. B., Marshall, J. F., Hurtig, H. I., Gottleib, G. L., & Joyce, J. N. (1995) · Annals of Neurology · doi:10.1002/ana.410370306 · Cited by 135
Extrapyramidal Signs in Patients With Probable Alzheimer Disease
López, O. L., Wisnieski, S. R., Becker, J. T., Boiler, F., & DeKosky, S. T. (1997) · Archives of Neurology · doi:10.1001/archneur.1997.00550200033007 · Cited by 133
Pathological correlates of extrapyramidal signs in Alzheimer's disease
Liu, Y., Stern, Y., Chun, M. R., Jacobs, D. M., Yau, P. O., & Goldman, J. E. (1997) · Annals of Neurology · doi:10.1002/ana.410410312 · Cited by 129
Changes in rat striatal dopamine turnover and receptor activity during one years neuroleptic
Clow, A., Theodorou, A. E., Jenner, P., et al. (1980) · European Journal of Pharmacology · doi:10.1016/0014-2999(80)90437-9 · Cited by 129
Neuroleptic sensitivity to risperidone in Lewy body dementia
McKeith, I. G., Ballard, C. G., & Harrison, R. W. S. (1995) · The Lancet · doi:10.1016/s0140-6736(95)92307-1 · Cited by 127
Self-citationRinne, J. O., Sahlberg, N., Ruottinen, H., Någren, K., & Lehikoinen, P. (1998) · Neurology · doi:10.1212/wnl.50.1.152 · Cited by 113
Dopamine D3 receptor is decreased and D2 receptor is elevated in the striatum of Parkinson's disease
Ryoo, H., Pierrotti, D., & Joyce, J. N. (1998) · Movement Disorders · doi:10.1002/mds.870130506 · Cited by 112
Morissette, M., Goulet, M., Grondin, R., Blanchet, P. J., Bédard, P. J., Paolo, T. D., & Lévesque, D. (1998) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1998.00264.x · Cited by 109
DRD2 Ser311/Cys311 polymorphism in schizophrenia
Nanko, S., Hattori, M., Dai, X., Fukuda, R., Kazamatsuri, H., Piggott, M. A., Perry, E., McKeith, I. G., Marshall, E., Perry, R., et al. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90167-8 · Cited by 103
Self-citationHerroelen, L., Backer, J.-P. D., Wilczak, N., Flamez, A., Vauquelin, G., & Keyser, J. D. (1994) · Brain Research · doi:10.1016/0006-8993(94)91121-5 · Cited by 95
The D-1 Dopamine Receptor and the Search for its Functional Role: From Neurochemistry to Behaviour
Waddington, J. L., & O’Boyle, K. M. (1987) · Reviews in the Neurosciences · doi:10.1515/revneuro.1987.1.3-4.157 · Cited by 94
The role of dopamine agonists in early Parkinson's disease
Watts, R. L. (1997) · Neurology · doi:10.1212/wnl.49.1_suppl_1.s34 · Cited by 89
Extrapyramidal Motor Signs in Clinically Diagnosed Alzheimer Disease
Ellis, R. J., Caligiuri, M. P., Galasko, D. R., & Thal, L. J. (1996) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-199601020-00008 · Cited by 88
Schröder, J., Silvestri, S., Bubeck, B., Karr, M., Demisch, S., Scherrer, S., Geider, F. J., & Sauer, H. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(97)00442-3 · Cited by 87
Graham, W. C., Sambrook, M. A., & Crossman, A. R. (1993) · Brain Research · doi:10.1016/0006-8993(93)90694-i · Cited by 85
Rb, C. (1982) · PubMed · Cited by 82
Clinical neurochemistry: developments in dementia research based on brain bank material
Perry, E. K., COURT, J. A., Goodchild, R. E., Griffiths, M., Jaros, E., Johnson, M. K., Lloyd, S. R., Piggott, M. A., Spurden, D., Ballard, C. G., et al. (1998) · Journal of Neural Transmission · doi:10.1007/s007020050102 · Cited by 80
Self-citationDopamine‐receptor autoradiography of human narcoleptic brain
Aldrich, M. S., Hollingsworth, Z. R., & Penney, J. B. (1992) · Neurology · doi:10.1212/wnl.42.2.410 · Cited by 80
Striatal dopamine receptors in Alzheimer-type dementia
Cross, A. J., Crow, T. J., Ferrier, I. N., Johnson, J. A., & Markakis, D. (1984) · Neuroscience Letters · doi:10.1016/0304-3940(84)90341-0 · Cited by 78
Pizzolato, G., Chierichetti, F., Fabbri, M., Cagnin, A., Dam, M., Ferlin, G., & Battistin, L. (1996) · Neurology · doi:10.1212/wnl.47.4.1065 · Cited by 77
Piggott, M. A., Marshall, E. F., Thomas, N., Lloyd, S. R., COURT, J. A., Jaros, E., Costa, D. C., Perry, R. H., & Perry, E. K. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00465-5 · Cited by 76
Self-citationKöhler, C., & Radesäter, A. (1986) · Neuroscience Letters · doi:10.1016/0304-3940(86)90170-9 · Cited by 73
Dopamine Uptake Sites and Dopamine Receptors in Parkinson’s Disease and Schizophrenia
Pearce, R. K. B., Seeman, P. M., Jellinger, K., & Tourtellotte, W. W. (2008) · European Neurology · doi:10.1159/000117168 · Cited by 72
Tyrrell, P. J., Sawle, G. V., Ibanez, V., Bloomfield, P. M., Leenders, K. L., Frackowiak, R. S. J., & Rossor, M. N. (1990) · Archives of Neurology · doi:10.1001/archneur.1990.00530120062011 · Cited by 68
Piggott, M. A., Perry, E. K., Marshall, E. F., McKeith, I. G., Johnson, M. K., Melrose, H. L., COURT, J. A., Lloyd, S. R., FAIRBAIRN, A. F., Brown, A. D., et al. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00127-9 · Cited by 67
Self-citationLewy Body Disease and Dementia: A Review
Kalra, S. (1996) · Archives of Internal Medicine · doi:10.1001/archinte.1996.00440050031004 · Cited by 67
Walker, Z., Costa, D. C., Janssen, A. G., Walker, R. W. H., Livingstone, G., & Katona, C. (1997) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/bf00841397 · Cited by 61
See, R. E., Toga, A. W., & Ellison, G. (1990) · Journal of Neural Transmission · doi:10.1007/bf01245166 · Cited by 60
Huang, N. (1997) · Neurochemistry International · doi:10.1016/s0197-0186(96)00093-9 · Cited by 57
Monoaminergic activities in Lewy Body dementia: Relation to hallucinosis and extrapyramidal features
Perry, E. K., Marshall, E., Thompson, P., McKeith, I. G., Collerton, D., FAIRBAIRN, A. F., Ferrier, I. N., Irving, D., & Perry, R. H. (1993) · Journal of Neural Transmission - Parkinsons Disease and Dementia Section · doi:10.1007/bf02260919 · Cited by 57
Self-citationVictoroff, J., Zarow, C., Mack, W. J., Hsu, E., & Chui, H. C. (1996) · Archives of Neurology · doi:10.1001/archneur.1996.00550050058024 · Cited by 53
Förstl, H., Levy, R., Burns, A. S., Luthert, P. J., & Cairns, N. (1994) · Pharmacopsychiatry · doi:10.1055/s-2007-1014267 · Cited by 52
123I‐β‐CIT and 123I‐IBZM‐SPECT scanning in levodopa‐naive Parkinson's disease
Wenning, G. K., Donnemiller, E., Granata, R., Riccabona, G., & Poewe, W. H. (1998) · Movement Disorders · doi:10.1002/mds.870130311 · Cited by 51
Substantia Nigra Lesions in Alzheimer Disease and Normal Aging
Kazee, A. M., Cox, C. E., & Richfield, E. K. (1995) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-199509020-00001 · Cited by 50
Gm, A., Schwartzman, R. J., Brainard, L., Gordon, S. W., & Grothusen, J. R. (1992) · Brain Research · doi:10.1016/0006-8993(92)91584-2 · Cited by 49
Modeling the Influence of Extrapyramidal Signs on the Progression of Alzheimer Disease
Stern, Y., Liu, X., Albert, M., Brandt, J., Jacobs, D. M., del Castillo–Castañeda, C., Marder, K. S., Bell, K. L., Sano, M., & Bylsma, F. (1996) · Archives of Neurology · doi:10.1001/archneur.1996.00550110061013 · Cited by 42
Cenesthetic hallucinations in a patient with Parkinson's disease
Jiménez-Jiménez, F. J., Pareja, M. O., Gasalla, T., Tallón-Barranco, A., Cabrera‐Valdivia, F., & FERNANDEZ-LLIRIA, A. (1997) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.63.1.120 · Cited by 38
[3H]Raclopride Binding to Brain Tissue from Subjects with Schizophrenia: Methodological Aspects
Dean, B., Pavey, G., & Opeskin, K. (1997) · Neuropharmacology · doi:10.1016/s0028-3908(97)00067-1 · Cited by 34
[3H] GBR 12935 binding to the dopamine uptake site in post-mortem brain tissue in schizophrenia
Czudek, C., & Reynolds, G. P. (1989) · Journal of Neural Transmission · doi:10.1007/bf01248935 · Cited by 31
Changes of monoamines in post-mortem brains from patients with diffuse Lewy body disease
Ohaea, K., Kondo, N., & Ohara, K. (1998) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(98)00006-2 · Cited by 28
Neuroleptics and Dopamine Transporters
Reader, T. A., Ase, A. R., Huang, N., Hébert, C., & van Gelder, N. M. (1998) · Neurochemical Research · doi:10.1023/a:1022405621365 · Cited by 27
A prospective study of dementia with Lewy bodies
Ballard, C. G., O'Brien, J. T., LOWERY, K., et al. (1998) · Age and Ageing · doi:10.1093/ageing/27.5.631 · Cited by 25
Self-citationUp-regulation of D3 dopamine receptor mRNA by neuroleptics
Wang, W., Hahn, K., Bishop, J. F., Gao, D., José, P. A., & Mouradian, M. M. (1996) · Synapse · doi:10.1002/(sici)1098-2396(199607)23:3<232::aid-syn13>3.0.co;2-0 · Cited by 24
Regional differences in chronic neuroleptic effects on extracellular dopamine activity
See, R. E., Chapman, M. A., Murray, C. E., & Aravagiri, M. (1992) · Brain Research Bulletin · doi:10.1016/0361-9230(92)90085-c · Cited by 24
Mizukawa, K., McGeer, E. G., & McGeer, P. L. (1993) · Molecular and Chemical Neuropathology · doi:10.1007/bf03160027 · Cited by 24
What is the neuropathological basis of dementia associated with Lewy bodies?
Perry, R. H., Jaros, E., Irving, D., Scoones, D. J., Brown, A., McMeekin, W., Perry, E. K., Morris, C. M., Kelly, P. J., & Ince, P. G. (1996) · Cambridge University Press eBooks · doi:10.1017/cbo9780511601187.022 · Cited by 23
Self-citationNo correlation between nigral degeneration and striatal plaques in Alzheimer's disease
Love, S., Wilcock, G., & Matthews, S. M. (1996) · Acta Neuropathologica · doi:10.1007/s004010050447 · Cited by 13
Neurochemical correlates of pathological and iatrogenic extrapyramidal symptoms
Piggott, M. A., & Marshall, E. F. (1996) · Cambridge University Press eBooks · doi:10.1017/cbo9780511601187.040 · Cited by 11
Self-citation
Cited by
Diagnosis and management of dementia with Lewy bodies: Third report of the DLB consortium
McKeith, I. G., Dickson, D. W., Lowe, J., Emre, M., O'Brien, J. T., Feldman, H., Cummings, J., Duda, J. E., Lippa, C., Perry, E. K., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000187889.17253.b1 · Cited by 5,069
Self-citationDiagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium
McKeith, I. G., Boeve, B. F., Dickson, D. W., Halliday, G., Taylor, J.-P., Weintraub, D., Aarsland, D., Galvin, J., Attems, J., Ballard, C. G., et al. (2017) · Neurology · doi:10.1212/wnl.0000000000004058 · Cited by 4,476
Self-citationDisease duration and the integrity of the nigrostriatal system in Parkinson’s disease
Kordower, J. H., Olanow, C. W., Dodiya, H. B., Chu, Y., Beach, T. G., Adler, C. H., Halliday, G. M., & Bartus, R. T. (2013) · Brain · doi:10.1093/brain/awt192 · Cited by 1,286
Zarow, C., Lyness, S. A., Mortimer, J. A., & Chui, H. C. (2003) · Archives of Neurology · doi:10.1001/archneur.60.3.337 · Cited by 1,002
McKeith, I., O'Brien, J., Walker, Z., Tatsch, K., Booij, J., Darcourt, J., Padovani, A., Giubbini, R., Bonuccelli, U., Volterrani, D., et al. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70057-1 · Cited by 716
Self-citation
Metadata
- Authors
- Piggott, M. A., Marshall, E. F., Thomas, N., Lloyd, S., Court, J. A., Jaros, E., Burn, D., Johnson, M., Perry, R. H., McKeith, I. G., Ballard, C., & Perry, E. K.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 1999-08
- Volume
- 122
- Issue
- 8
- Pages
- 1449-1468
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2133218279
- Cited by
- 330
- References
- 96
- FWCI
- 8.72
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.